394 related articles for article (PubMed ID: 9048834)
1. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
2. Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.
Sparano JA; Wiernik PH; Strack M; Leaf A; Becker NH; Sarta C; Carney D; Elkind R; Shah M; Valentine ES
Leuk Lymphoma; 1994 Jul; 14(3-4):263-71. PubMed ID: 7950915
[TBL] [Abstract][Full Text] [Related]
3. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Sparano JA; Wiernik PH; Hu X; Sarta C; Schwartz EL; Soeiro R; Henry DH; Mason B; Ratech H; Dutcher JP
J Clin Oncol; 1996 Nov; 14(11):3026-35. PubMed ID: 8918501
[TBL] [Abstract][Full Text] [Related]
4. Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.
Sparano JA; Wiernik PH; Strack M; Leaf A; Becker N; Valentine ES
Blood; 1993 May; 81(10):2810-5. PubMed ID: 8490187
[TBL] [Abstract][Full Text] [Related]
5. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
Ramos JC; Sparano JA; Chadburn A; Reid EG; Ambinder RF; Siegel ER; Moore PC; Rubinstein PG; Durand CM; Cesarman E; Aboulafia D; Baiocchi R; Ratner L; Kaplan L; Capoferri AA; Lee JY; Mitsuyasu R; Noy A
Blood; 2020 Sep; 136(11):1284-1297. PubMed ID: 32430507
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma.
Gabarre J; Lepage E; Thyss A; Tubiana R; Bastion Y; Schlaifer D; Sebban C; Ribrag V; Fereres M; Raphael M
Ann Oncol; 1995 Dec; 6(10):1025-32. PubMed ID: 8750156
[TBL] [Abstract][Full Text] [Related]
7. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
Kaplan LD; Shiramizu B; Herndier B; Hahn J; Meeker TC; Ng V; Volberding PA; McGrath MS
Blood; 1995 Apr; 85(7):1727-35. PubMed ID: 7535586
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
Gisselbrecht C; Oksenhendler E; Tirelli U; Lepage E; Gabarre J; Farcet JP; Gastaldi R; Coiffier B; Thyss A; Raphael M
Am J Med; 1993 Aug; 95(2):188-96. PubMed ID: 7689296
[TBL] [Abstract][Full Text] [Related]
9. Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program.
Sawka CA; Shepherd FA; Brandwein J; Burkes RL; Sutton DM; Warner E
Leuk Lymphoma; 1992 Oct; 8(3):213-20. PubMed ID: 1283356
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.
Rubio R
Cancer; 1994 May; 73(9):2400-7. PubMed ID: 8168044
[TBL] [Abstract][Full Text] [Related]
11. Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
Mwanda WO; Orem J; Fu P; Banura C; Kakembo J; Onyango CA; Ness A; Reynolds S; Johnson JL; Subbiah V; Bako J; Wabinga H; Abdallah FK; Meyerson HJ; Whalen CC; Lederman MM; Black J; Ayers LW; Katongole-Mbidde E; Remick SC
J Clin Oncol; 2009 Jul; 27(21):3480-8. PubMed ID: 19470940
[TBL] [Abstract][Full Text] [Related]
12. Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol.
Schürmann D; Grünewald T; Weiss R; Jautzke G; Pohle HD; Ruf B
Eur J Haematol; 1995 Feb; 54(2):73-7. PubMed ID: 7535244
[TBL] [Abstract][Full Text] [Related]
13. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
Vaccher E; Tirelli U; Spina M; Talamini R; Errante D; Simonelli C; Carbone A
J Clin Oncol; 1996 Aug; 14(8):2217-23. PubMed ID: 8708710
[TBL] [Abstract][Full Text] [Related]
14. Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma.
Lurain K; Ramaswami R; Mangusan R; Widell A; Ekwede I; George J; Ambinder R; Cheever M; Gulley JL; Goncalves PH; Wang HW; Uldrick TS; Yarchoan R
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33608378
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Lévy R; Colonna P; Tourani JM; Gastaut JA; Brice P; Raphaël M; Taillan B; Andrieu JM
Leuk Lymphoma; 1995 Feb; 16(5-6):451-6. PubMed ID: 7540459
[TBL] [Abstract][Full Text] [Related]
16. Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma.
Remick SC; McSharry JJ; Wolf BC; Blanchard CG; Eastman AY; Wagner H; Portuese E; Wighton T; Powell D; Pearce T
J Clin Oncol; 1993 Sep; 11(9):1691-702. PubMed ID: 8355036
[TBL] [Abstract][Full Text] [Related]
17. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
Kaplan LD; Straus DJ; Testa MA; Von Roenn J; Dezube BJ; Cooley TP; Herndier B; Northfelt DW; Huang J; Tulpule A; Levine AM
N Engl J Med; 1997 Jun; 336(23):1641-8. PubMed ID: 9171066
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
[TBL] [Abstract][Full Text] [Related]
19. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Moore RD; Chaisson RE
Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
[TBL] [Abstract][Full Text] [Related]
20. Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; van Dyk U; Stoehr A; Albrecht H; Stellbrink HJ; Berger J; Meigel W
Dermatology; 1997; 194(3):234-7. PubMed ID: 9187839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
